HOOK - HOOKIPA Pharma Inc.

-

$undefined

N/A

(N/A)

HOOKIPA Pharma Inc. NASDAQ:HOOK HOOKIPA Pharma Inc. is a clinical-stage biopharmaceutical company developing a new class of immunotherapeutics based on its proprietary arenavirus platform that reprograms the body's immune system.

Location: | Website: www.hookipapharma.com | Industry: Research and Development in Biotechnology | Sector: Professional, Scientific, and Technical Services


Market Cap

NaN

52 Wk Range

$ - $

Previous Close

$N/A

Open

$N/A

Day Range

N/A - N/A

Volume

N/A

Avg Volume

N/A

Enterprise Value

-27.29M

Cash

77.15M

Avg Qtr Burn

-18.47M

Short % of Float

0.38%

Insider Ownership

21.44%

Institutional Own.

36.89%

Qtr Updated

06/30/24


Drug Pipeline

Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & IndicationStage & EventCatalyst Date
HB-200 (TheraT® LCMV) + pembrolizumab Details
Cancer, Human papillomavirus, Head and neck squamous cell carcinoma

Phase 2/3

Initiation

HB-400 Details
Hepatitis B

Phase 2

Initiation

HB-202/HB-201 Details
Cancer, Human papillomavirus

Phase 1/2

Data readout

HB-500 Details
Human immunodeficiency virus

Phase 1b

Data readout

HB-700 Details
Cancer, Lung cancer, Colorectal cancer , Pancreatic cancer

Phase 1

Initiation

HB-101 (VaxWave®) Details
Cytomegalovirus, Infectious disease, Kidney transplantation

Failed

Discontinued

HB-300 Details
Cancer, Castration-resistant prostate cancer

Failed

Discontinued